Influence of TLR-2 in the immune response in the infection induced by fungus Sporothrix schenckii

References

• Akira S, Uematsu S, Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell, 124, 783–801
   PubMed Web of Science ®Google Scholar
• Alegranci P, de Abreu Ribeiro LC, Ferreira LS, et al. (2013). The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii. Mycopathologia, 176, 57–65
   Google Scholar
• Barros MB, Schubach AO, Schubach TM, et al. (2008). An epidemic of sporotrichosis in Rio de Janeiro, Brazil: Epidemiological aspects of a series of cases. Epidemiol Infect, 136, 1192–6
   Google Scholar
• Bozza S, Zelante T, Moretti S, et al. (2008). Lack of Toll IL-1R8 Exacerbates Th17 cell responses in fungal infection. J Immunol, 180, 4022–31
   PubMed Web of Science ®Google Scholar
• Braedel S, Radsak M, Einsele H, et al. (2004). Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol, 125, 392–9
   PubMed Web of Science ®Google Scholar
• Bustamante B, Campos PE. (2001). Endemic sporothricosis. Curr Opin Infect Dis, 14, 145–9
   PubMed Web of Science ®Google Scholar
• Carlos IZ, Sgarbi DBG, Santos GC, Placeres MCP. (2003). Sporothrix schenckii lipid inhibits macrophage phagocytosis, involvement of nitric oxide and tumor necrosis factor-α. Scand J Immunol, 57, 214–20
   PubMed Web of Science ®Google Scholar
• Carlos IZ, Zini MM, Sgarbi DBG, et al. (1994). Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia, 127, 189–94
   PubMed Web of Science ®Google Scholar
• Carlos IZ, Sgarbi DB, Angluster J, et al. (1992). Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia, 117, 139–44
   Google Scholar
• Chai LY, Vonk AG, Kullberg BJ, et al. (2011). Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses. Microbes Infect, 13, 151–9
   PubMed Web of Science ®Google Scholar
• Chen Z, Tato CM, Muul L, et al. (2007). Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum, 56, 2936–46
   PubMed Web of Science ®Google Scholar
• da Rosa AC, Scroferneker ML, Vettorato R, et al. (2005). Epidemiology of sporotrichosis: A study of 304 cases in Brazil. J Am Acad Dermatol, 52, 451–9
   PubMed Web of Science ®Google Scholar
• Dusse LMS, Vieira LM, Carvalho MG. (2003). Revisão sobre óxido nítrico. Jornal Brasileiro de Patologia e Medicina Laboratorial, 39, 343–50
   Google Scholar
• Ghoreschi K, Laurence A, Yang XP, et al. (2010). Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature, 467, 967–71
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem, 126, 131–8
   PubMed Web of Science ®Google Scholar
• Hardman S, Stephenson I, Jenkins DR, et al. (2005). Disseminated Sporothix schenckii in a patient with AIDS. J Infect, 51, 73–7
   Google Scholar
• Joshi A, Pancari G, Cope L, et al. (2012). Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Hum Vaccin Immunother, 8, 336–46
   PubMed Web of Science ®Google Scholar
• Kauffman CA. (1999). Sporotrichosis. Clin Infect Dis, 29, 231–6
   PubMedGoogle Scholar
• Kawai T, Akira S. (2010). The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol, 11, 373–84
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. (2007). Signaling to NF-kB by Toll-like receptors. Trends Mol Med, 13, 460–9
   PubMed Web of Science ®Google Scholar
• Kondo T, Kawai T, Akira S. (2012). Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol, 3, 449–58
   Google Scholar
• Korn T, Oukka M, Kuchroo V, Bettelli E. (2007). Th17 cells: Effector T cells with inflammatory properties. Semin Immunol, 19, 362–71
   PubMed Web of Science ®Google Scholar
• Lee HJ, Cho JW, Kim SC, et al. (2006). Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-alpha- and dexamethasone-stimulated human periodontal ligament cells. Cytokine, 35, 67–76
   Google Scholar
• Li M, Chen Q, Sun J, et al. (2012). Inflammatory response of human keratinocytes triggered by Sporothrix schenckii via Toll-like receptor 2 and 4. J Dermatol Sci, 66, 80–2
   Google Scholar
• Lin Y, Slight SR, Khader SA. (2010). Th17 cytokines and vaccine-induced immunity. Semin Immunopathol, 32, 79–90
   PubMedGoogle Scholar
• Liu G, Zhang L, Zhao Y. (2010). Modulation of immune responses through direct activation of Toll-like receptors to T cells. Clin Exp Immunol, 160, 168–75
   PubMed Web of Science ®Google Scholar
• Lopes-Bezerra LM, Schubach A, Costa RO. (2006). Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc, 78, 293–308
   PubMedGoogle Scholar
• Loures FV, Pina A, Felonato M, Calich VL. (2009). TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol, 183, 1279–90
   PubMed Web of Science ®Google Scholar
• Maia DC, Sassá MF, Placeres MC, Carlos IZ. (2006). Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii. Mycopathologia, 161, 11–19
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O’Quinn DB, et al. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441, 231–34
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, McSorley SJ. (2012). Microbial-induced Th17: Superhero or supervillain? J Immunol, 189, 3285–91
   PubMed Web of Science ®Google Scholar
• McGettrick AF, O'Neill LA. (2010). Localisation and trafficking of Toll-like receptors: An important mode of regulation. Curr Opin Immunol, 22, 20–7
   PubMed Web of Science ®Google Scholar
• Meier A, Kirschning CJ, Nikolaus T, et al. (2003). Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol, 5, 561–70
   PubMed Web of Science ®Google Scholar
• Mesquita D Jr, Cruvinel WM, Câmara NO, et al. (2009). Autoimmune diseases in the TH17 era. Braz J Med Biol Res, 42, 476–86
   Google Scholar
• Moseley TA, Haudenschild DR, Rose L, Reddi AH. (2003). Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev, 14, 155–74
   PubMed Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth, 65, 55–63
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Sato H, Watanabe S, et al. (1996). Sporothrix schenckii isolated from a cat in Japan. Mycoses, 39, 125–8
   Google Scholar
• Negrini TC, Ferreira LS, Arthur RA, et al. (2013). Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol Invest, 42, 36–48
   Web of Science ®Google Scholar
• Netea MG, Sutmuller R, Hermann C, et al. (2004). Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol, 172, 3712–8
   PubMed Web of Science ®Google Scholar
• Netea MG, Van der Graaf CA, Vonk AG, et al. (2002). The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis, 185, 1483–9
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. (2008). The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity, 28, 454–67
   PubMed Web of Science ®Google Scholar
• Ramos-E-Silva M, Vasconcelos C, Carneiro S, Cestari T. (2007). Sporotrichosis. Clin Dermatol, 25, 181–7
   PubMed Web of Science ®Google Scholar
• Robinson KM, Manni ML, Biswas PS, Alcorn JF. (2013). Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders. Curr Allergy Asthma Rep, 13, 587--95
   Google Scholar
• Romani L. (2004). Immunity to fungal infections. Nat Rev Immunol, 4, 1–23
   PubMed Web of Science ®Google Scholar
• Romani L. (2011). Immunity to fungal infections. Nat Rev Immunol, 11, 275–88
   PubMed Web of Science ®Google Scholar
• Sassá MF, Ferreira LS, Ribeiro LC, Carlos IZ. (2012). Immune response against Sporothrix schenckii in TLR-4-deficient mice. Mycopathologia, 174, 21–30
   Google Scholar
• Sassá MF, Saturi AE, Souza LF, et al. (2009). Response of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology, 128, 301–9
   PubMed Web of Science ®Google Scholar
• Schubach A, Barros MB, Wanke B. (2008). Epidemic sporotrichosis. Curr Opin Infect Dis, 21, 129–33
   PubMedGoogle Scholar
• Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. (2003). Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol, 21, 713–58
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. (2005). Toll-like receptors in innate immunity. Int Immunol, 17, 1–14
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. (2003). Toll-like receptors. Annu Rev Immunol, 21, 335–76
   PubMed Web of Science ®Google Scholar
• Torre D, Speranza F, Martegani R. (2002). Role of proinflammatory and anti-inflammatory cytokines in the immune response to Plasmodium falciparum malaria. Lancet Infect Dis, 2, 719–20
   Google Scholar
• Underhill DM, Ozinsky A. (2002). Phagocytosis of microbes: Complexity in action. Annu Rev Immunol, 20, 825–52
   PubMed Web of Science ®Google Scholar
• Underhill DM, Ozinsky A, Hajjar AM, et al. (1999). The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature, 401, 811–5
   PubMed Web of Science ®Google Scholar
• Villamón E, Gozalbo D, Roig P, et al. (2004a). Toll-like receptor-2 is essential in murine defensas against Candida albicans infections. Microbes Infect, 6, 1–7
   PubMed Web of Science ®Google Scholar
• Villamón E, Gozalbo D, Roig P, et al. (2004b). Toll-like receptor-2 is dispensable for acquired host immune resistance to Candida albicans in a murine model disseminated candidiasis. Microbes Infect, 6, 542–8
   PubMed Web of Science ®Google Scholar
• Volpe E, Servant N, Zollinger R, et al. (2008). A critical function for transforming growth factor-b, interleukin-23 and proinflammatory cytokines in driving and modulating human Th17 responses. Nat Immunol, 9, 65–7
   Google Scholar
• Weaver CT, Harrington LE, Mangan PR, et al. (2006). Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity, 24, 677–88
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, Harrington LE. (2007). IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol, 25, 821–52
   PubMed Web of Science ®Google Scholar
• Wing JB, Sakaguchi S. (2012). Multiple treg suppressive modules and their adaptability. Front Immunol, 3, 178. doi: 10.3389/fimmu.2012.00178. eCollection 2012
   PubMed Web of Science ®Google Scholar
• Ye P, Rodriguez FH, Kanaly S, et al. (2001). Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med, 194, 519–27
   PubMed Web of Science ®Google Scholar